CBD may not in itself offer a cure for the devastating coronavirus in humans, but it may play a larger role in treating canine coronavirus, experts say. The interplay between coronavirus in animals — such as fowl, dogs, pigs and cows — and humans is still being studied and may have played a role in the current global spread of the disease. While CBD is not a cure for coronavirus in humans, it has properties that address key elements. CBD is known to offer anti-viral, anti-inflammatory and anti-bacterial properties. It also acts as an effective treatment for nausea and vomiting, which can be induced by the coronavirus in humans.
The impact of the coronavirus globally has also intensified coverage of CBD according to companies such as stockmarketpress.com which features coverage of CBD related stocks like CBD Unlimited, Inc. (OTC PINK: EDXC), Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC:SPRWF) and OrganiGram Holdings Inc. (NASDAQ: OGI).
CBD’s role in fighting canine coronavirus
In dogs, the canine coronavirus is an intestinal infection which can be transmitted by exposure to the feces of an infected dog according to the site thoughtcloud.net. Overcrowding and unsanitary conditions can also be factors in its transmission, experts report. While CBD may not be a cure for coronavirus in humans, it may play a larger role in treating canine coronavirus.
CBD can help fight canine coronavirus, due to its anti-inflammatory and antiemetic properties. CBD oil also has antiviral properties making it a potent cannabinoid to fight the virus. CBD can also fight the feeling of nausea in dogs suffering from canine coronavirus. A veterinarian may prescribe antibiotics, too. While CBD may not be a cure for coronavirus in humans, it may play a larger role in treating canine coronavirus. It has qualities associated with painkilling, anti-viral, anti-nausea and may even strengthen the immune system.
CBD Unlimited, Inc. (otc pink:EDXC) identified the CBD pet market as an important opportunity. It produces and markets a line of CBD chews, oils and equine products that bring the benefits of CBD to pets. The Brightfield Group estimates that the U.S. pet CBD market will reach $1.7 billion by 2023. That’s quick growth because according to the corporate presentation of CBD Unlimited, Inc. (otc pink:EDXC) the pet CBD market was at some $500 million last year. Reaching $1.7 billion in a few years means that the CBD pet market is exploding in sales. The company explains that its pet CBD products are hemp-derived, THC free and specifically formulated for pets and equines.
While CBD is not seen as a cure for the coronavirus in humans, it has numerous important properties that address issues felt by individuals who contract the illness, experts said. While CBD may not be a cure for coronavirus, it offers anti-viral, anti-inflammatory and anti-bacterial properties. These are significant for people who contract the coronavirus and become nauseas, vomit, and experience any inflammation. Also, CBD is known to reduce stress and anxiety issues. All of these properties are helpful in fighting the disease. The coronavirus (COVID19) could become a worldwide pandemic.
CBD Unlimited, Inc. (OTC PINK: EDXC) makes sure its CBD products — whether marketed for humans or pets — are highest quality, American-manufactured and tightly controlled by a seed-to-shelf strategy, meaning its hemp is certified and grown in Colorado and Kentucky. It has premium genetics and superior quality, the company said in its recent corporate presentation. Its extracts in processing are rich in phyto-cannabinoids and terpenoids which are non-psychoactive. The product is also cGMP Certified (Good Manufacturing Practice Certification).
Source: Stock Market Press (stockmarketpress.com), 110 Wall St., New York, NY 10005 email: firstname.lastname@example.org
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Safe Harbor Statement: Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.